Industry news that matters to you.  Learn more

Archives for July 2011

Biomarker Briefs: July 25, 2011

Biomarker Briefs is an occasionally recurring series highlighting particularly interesting articles on biomarkers and/or personalized medicine.

FDA, EMA Seek Input on Companion Diagnostics, Genomic Biomarkers

Regulators in the U.S. and Europe have each posted requests for public comment on issues affecting the development of medicines by drug companies.

Thermo Fisher Scientific Signs Agreement to Make its Biomarker Assays Available on Alere Triage Systems

Thermo Fisher Scientific, the world leader in serving science, today announced it has signed a long-term license agreement with Alere Inc. to integrate its novel Thermo Scientific B.R.A.H.M.S. biomarker assays on Alere’s leading point-of-care Triage platform. Alere, formerly Inverness Medical Innovations, is a global leader in rapid point-of-care diagnostics. Increased availability of biomarker-based testing on the Triage platform will lead to improved patient care in hospitals and primary care facilities.

Exonhit and BGI Announce Successful Completion of a Promising Next-generation Sequencing Project

Exonhit, a biotech company focused on personalized medicine, and BGI, the world’s largest genome organization, are pleased to announce the successful completion of a project dedicated to expanding Exonhit’s Genome Wide SpliceArray to an additional strategic preclinical animal model species.

RadMD Presents at BIO International Convention 2011

Dr. Kohkan Shamsi, Principal at RadMD, led one of the key Biomarker sessions at this year’s annual BIO International Convention in Washington DC. The event features keynotes and sessions from key policymakers, scientists, CEOs, and celebrities. The Convention also features hundreds of sessions covering biotech trends, policy issues and technological innovations, as well as the world’s largest biotechnology exhibition.